Artesunate Protects LPS-Induced Acute Lung Injury by Inhibiting TLR4 Expression and Inducing Nrf2 Activation

Overview

Journal Inflammation

Specialties Allergy & Immunology
Pathology

Date 2017 Mar 20

PMID 28315999

Citations 26

Authors

Deli Zhao

Jinling Zhang

Guangquan Xu

Qiushi Wang

Affiliations

Soon will be listed here.

Abstract

Artesunate, a derivative of artemisinin, has been reported to have anti-inflammatory property. However, few studies showed the protective effects of artesunate on lung injury. In this study, we aimed to investigate the effects of artesunate on LPS-induced lung injury in mice. The mice were treated with artesunate 1 h before or after LPS treatment. The effects of artesunate on lung MPO activity and malondialdehyde (MDA) content were detected. The lung wet/dry radio and the numbers of inflammatory cells in BALF were also measured. ELISA was used to evaluate the levels of TNF-α, IL-1β, and IL-6 in BALF. Western blot analysis was adapted to detect TLR4 and Nrf2 signaling pathways. The results showed that artesunate protected against LPS-induced ALI by decreasing the numbers of inflammatory cells, lung edema, MPO activity, and MDA content. Furthermore, artesunate significantly inhibited the levels of TNF-α, IL-1β, and IL-6. Artesunate also inhibited LPS-induced IL-6 and IL-8 production in the A549 cells. In addition, artesunate dose-dependently suppressed LPS-induced TLR4 expression and NF-κB activation. The expression of Nrf2 and HO-1 were also up-regulated by artesunate. The data suggest that artesunate possesses anti-inflammatory and anti-oxidant properties against LPS-induced ALI via inhibiting TLR4 signaling pathway and activating Nrf2 signaling pathway.

Citing Articles

Protective effect of Haoqin Qingdan decoction on pulmonary and intestinal injury in mice with influenza viral pneumonia.

Lin X, Lin J, Ji L, Zhang J, Zhang Y, Hong J Front Pharmacol. 2024; 15:1449322.

PMID: 39712501 PMC: 11658977. DOI: 10.3389/fphar.2024.1449322.

Artesunate protects against a mouse model of cerulein and lipopolysaccharide‑induced acute pancreatitis by inhibiting TLR4‑dependent autophagy.

Liu D, Liu C, Deng F, Ouyang F, Qin R, Zhai Z Int J Mol Med. 2024; 55(2).

PMID: 39635846 PMC: 11637502. DOI: 10.3892/ijmm.2024.5466.

In Situ-Activated Phospholipid-Mimic Artemisinin Prodrug via Injectable Hydrogel Nano/Microsphere for Rheumatoid Arthritis Therapy.

Du Y, Li C, Zhang Y, Xiong W, Wang F, Wang J Research (Wash D C). 2024; 2022:0003.

PMID: 39290968 PMC: 11407526. DOI: 10.34133/research.0003.

Artesunate Exerts Organ- and Tissue-Protective Effects by Regulating Oxidative Stress, Inflammation, Autophagy, Apoptosis, and Fibrosis: A Review of Evidence and Mechanisms.

Zhu M, Wang Y, Han J, Sun Y, Wang S, Yang B Antioxidants (Basel). 2024; 13(6).

PMID: 38929125 PMC: 11200509. DOI: 10.3390/antiox13060686.

Xuanfei Baidu decoction in the treatment of coronavirus disease 2019 (COVID-19): Efficacy and potential mechanisms.

Meng T, Ding J, Shen S, Xu Y, Wang P, Song X Heliyon. 2023; 9(9):e19163.

PMID: 37809901 PMC: 10558324. DOI: 10.1016/j.heliyon.2023.e19163.

References

Baumann W, Jung R, Koss M, Boylen C, Navarro L, Sharma O . Incidence and mortality of adult respiratory distress syndrome: a prospective analysis from a large metropolitan hospital. Crit Care Med. 1986; 14(1):1-4. DOI: 10.1097/00003246-198601000-00001. View

Ben D, Yu X, Ji G, Zheng D, Lv K, Ma B . TLR4 mediates lung injury and inflammation in intestinal ischemia-reperfusion. J Surg Res. 2011; 174(2):326-33. DOI: 10.1016/j.jss.2010.12.005. View

Lai L, Chen Y, Tian X, Li X, Zhang X, Lei J . Artesunate alleviates hepatic fibrosis induced by multiple pathogenic factors and inflammation through the inhibition of LPS/TLR4/NF-κB signaling pathway in rats. Eur J Pharmacol. 2015; 765:234-41. DOI: 10.1016/j.ejphar.2015.08.040. View

Imai Y, Kuba K, Neely G, Yaghubian-Malhami R, Perkmann T, van Loo G . Identification of oxidative stress and Toll-like receptor 4 signaling as a key pathway of acute lung injury. Cell. 2008; 133(2):235-49. PMC: 7112336. DOI: 10.1016/j.cell.2008.02.043. View

Wheeler A, Bernard G . Acute lung injury and the acute respiratory distress syndrome: a clinical review. Lancet. 2007; 369(9572):1553-1564. DOI: 10.1016/S0140-6736(07)60604-7. View

Enkhbaatar P, Traber D . Pathophysiology of acute lung injury in combined burn and smoke inhalation injury. Clin Sci (Lond). 2004; 107(2):137-43. DOI: 10.1042/CS20040135. View

Urso M, Clarkson P . Oxidative stress, exercise, and antioxidant supplementation. Toxicology. 2003; 189(1-2):41-54. DOI: 10.1016/s0300-483x(03)00151-3. View

Zhang X, Shan P, Qureshi S, Homer R, Medzhitov R, Noble P . Cutting edge: TLR4 deficiency confers susceptibility to lethal oxidant lung injury. J Immunol. 2005; 175(8):4834-8. DOI: 10.4049/jimmunol.175.8.4834. View

Goodman R, Pugin J, Lee J, Matthay M . Cytokine-mediated inflammation in acute lung injury. Cytokine Growth Factor Rev. 2003; 14(6):523-35. DOI: 10.1016/s1359-6101(03)00059-5. View

10.

Kristof A, Goldberg P, Laubach V, Hussain S . Role of inducible nitric oxide synthase in endotoxin-induced acute lung injury. Am J Respir Crit Care Med. 1998; 158(6):1883-9. DOI: 10.1164/ajrccm.158.6.9802100. View

11.

Zhang B, Liu Z, Li Y, Luo Y, Liu M, Dong H . Antiinflammatory effects of matrine in LPS-induced acute lung injury in mice. Eur J Pharm Sci. 2011; 44(5):573-9. DOI: 10.1016/j.ejps.2011.09.020. View

12.

Seki H, Fukunaga K, Arita M, Arai H, Nakanishi H, Taguchi R . The anti-inflammatory and proresolving mediator resolvin E1 protects mice from bacterial pneumonia and acute lung injury. J Immunol. 2009; 184(2):836-43. PMC: 3000830. DOI: 10.4049/jimmunol.0901809. View

13.

Okorji U, Olajide O . A semi-synthetic derivative of artemisinin, artesunate inhibits prostaglandin E2 production in LPS/IFNγ-activated BV2 microglia. Bioorg Med Chem. 2014; 22(17):4726-34. DOI: 10.1016/j.bmc.2014.07.007. View

14.

Cho H, Jedlicka A, Reddy S, Kensler T, Yamamoto M, Zhang L . Role of NRF2 in protection against hyperoxic lung injury in mice. Am J Respir Cell Mol Biol. 2002; 26(2):175-82. DOI: 10.1165/ajrcmb.26.2.4501. View

15.

Yang Z, Ding J, Yang C, Gao Y, Li X, Chen X . Immunomodulatory and anti-inflammatory properties of artesunate in experimental colitis. Curr Med Chem. 2012; 19(26):4541-51. DOI: 10.2174/092986712803251575. View

16.

Fitzgerald K, Rowe D, Barnes B, Caffrey D, Visintin A, Latz E . LPS-TLR4 signaling to IRF-3/7 and NF-kappaB involves the toll adapters TRAM and TRIF. J Exp Med. 2003; 198(7):1043-55. PMC: 2194210. DOI: 10.1084/jem.20031023. View

17.

Leung L, Kwong M, Hou S, Lee C, Chan J . Deficiency of the Nrf1 and Nrf2 transcription factors results in early embryonic lethality and severe oxidative stress. J Biol Chem. 2003; 278(48):48021-9. DOI: 10.1074/jbc.M308439200. View

18.

Ueda K, Ueyama T, Yoshida K, Kimura H, Ito T, Shimizu Y . Adaptive HNE-Nrf2-HO-1 pathway against oxidative stress is associated with acute gastric mucosal lesions. Am J Physiol Gastrointest Liver Physiol. 2008; 295(3):G460-9. DOI: 10.1152/ajpgi.00204.2007. View

19.

Welbourn C, Young Y . Endotoxin, septic shock and acute lung injury: neutrophils, macrophages and inflammatory mediators. Br J Surg. 1992; 79(10):998-1003. DOI: 10.1002/bjs.1800791006. View

20.

Jiang D, Liang J, Fan J, Yu S, Chen S, Luo Y . Regulation of lung injury and repair by Toll-like receptors and hyaluronan. Nat Med. 2005; 11(11):1173-9. DOI: 10.1038/nm1315. View